Skip to main content

Advertisement

Table 2 Demographic characteristics, severity and actions taken for episodes of acute fever in the two weeks preceding the survey according to socio-economic status and geographic location

From: Treatment of Febrile illness with artemisinin combination therapy: prevalence and predictors in five African household surveys

Individuals with recent acute fever (N) Poor Non-Poor   Outside Capital Within Capital  
  652 1384   1671 329  
  Proportion Estimates(95% Confindence Intervals) Pearson chi2 Proportion Estimates(95% Confindence Intervals) Pearson chi2
Country    p<0.001    p<0.001
Gambia 8.2(5.1,13.2) 20.2(12.8,30.4)   6.8(4.3,10.8) 25.9  
Ghana 9.0(5.1,15.3) 14.7(10.0,21.0)   15.2(10.1,22.3) 5.6(1.8,16.2)  
Kenya 33.9(23.5,46.1) 18.3(12.3,26.4)   29.2(20.7,39.5) 4.3(1.6,11.3)  
Negeria 16.4(9.7,26.4) 20..4(14.2,28.4)   21.2(14.5,29.8) 12.7(5.0,28.9)  
Uganda 32.5(22.1,44.9) 26.4(18.3,36.1)   27.6(19.3,37.9) 30.5(13.7, 54.9)  
Female 52.7(48.3,57.2) 55.9(52.3,59.3) ns 54.1(51.2,57.0) 57.4(50.0,64.4) ns
Age umder 44.4(38.8,50.1) 36.5(33.2,40.0) ns 40.3(36.7,44.1) 34.7(229.9,39.9) ns
Very severe fever 19.6(15.8,24.1) 19.6(17.1,22.4) ns 21.8(19.1,24.9) 12.6(9.5,16.4) p<0.001
Reported associated symptoms    ns    ns
Upper respiratory (cough, runny nose, sore throat, earache) 33.5(27.9,39.6) 36.0(31.4,40.8) ns 36.8(32.4,41.4) 30.1(22.7,38.7) ns
Difficulty breathing, fast breathing 7.1(5.1,9.8) 6.0(4.5,7.9) ns 7.1(5.6,9.1) 3.8(2.0,7.3) ns
Gastro-interstinal (diarrhea, nausea, could not eat) 25.1(20.8,29.9) 22.8(19.0,27.0) ns 23.5(20.5,26.8) 23.5(15.1,34.7) ns
All other symptoms 35.9(28.44.2) 42.2(37.2,47.3) ns 38.7(33.0,44.8) 44.8(35.5,54.4) ns
Actions taken       
Sought care outside home 88.3(84.4,91.4) 93.4(91.8,94.8) p<0.005 91.1(88.8,92.9) 94.3(91.6,96.1) ns
traveled more than one hour to recieve care 23.3(16.6,31.6) 13.1(10.6,15.9) p<0.001 17.4(13.7,22.0) 12.5(8.3,18.5) ns
received in a public health facility 52.1(46.1,58.0) 50.8(46.1,55.4) ns 53.6(49.2,57.9) 43.6(33.7,54.0) p<0.05
Treatment       
Received medicines 95.3(92.6,97.0) 96.4(94.8,97.5) ns 96.6(95.3,97.5) 94.4(89.5,97.0) ns
obtained all medicines free-of-charge 31.2(25.4,37.7) 30.6(26.1,35.6) ns 32.8(27.7,38.8) 24.4(17.7,32.6) ns
Received antimalarials 64.2(59.1,68.9) 68.3(64.9,71.5) ns 67.5(63.9,70.9) 65.4(59.6,70.8) ns
obtained antimalarials and other medicines in public facility 36.7(31.1,42.7) 33.5(29.8,37.4) ns 36.7(40.9) 27.5(20.2,36.2) ns
received ACT 18.5(13.9,24.2) 15.2(12.2,18.7) ns 18.5(15.2,22.4) 9.0(4.7,16.7) p<0.05
obtained ACT and other medicines in public in facility 13.5(9.8,18.5) 10.6(8.3,13.5) ns 14.4(11.5,17.8) 2.7(1.1,6.2) p<0.0001
obtained all medicines including ACT free-of-charge 10.3(7.0,15.0) 6.9(5.0,9.4) ns 9.9(7.4,13.1) 1.7(0.6,4.5) p<0.001
Received antibiotics 31.3(26.9,36.0) 31.4(27.5,35.6) ns 34.8(31.2,38.5) 20.7(14.28.5) p<0.005
Received analgesics or NSAIDs 65.2(59.9,70.2) 70.6(67.3,73.8) p<0.05 69.3(66.2,72.3) 67.6(58.7,75.4) ns